.webp)
Share
Dr. Ingrid Müller
Evotec SE has appointed Dr. Ingrid Müller as Chief Operating Officer (COO).
She will also join Evotec’s Management Board.
Dr. Müller brings more than 20 years of international leadership experience in the life sciences industry, with expertise spanning operations, strategy, supply chain management, procurement, and R&D integration. In her role as COO, she will be responsible for overseeing Evotec’s global operations and driving the execution of the company’s Horizon initiative, with a focus on improving quality, productivity, scalability, delivery performance, and cost efficiency, while advancing technological innovation across the business.
Prior to joining Evotec, Dr. Müller served as Vice President of Portfolio Strategy & Execution at CureVac. She has also held senior leadership positions at Sanofi and Fresenius Kabi, where she contributed to strengthening supply chain resilience, implementing make-or-buy strategies, supporting business growth and margin expansion, and delivering cost savings and cash-flow improvements.
With her extensive operational and strategic experience, Dr. Müller is expected to play a key role in enhancing Evotec’s global execution capabilities and long-term operational performance.
